ONCTERNAL THERAPEUTICS INC (ONCT)
US68236P1075 - Common Stock
ChartMill assigns a Buy % Consensus number of 75% to ONCT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.94. This target is 554.73% above the current price.
ONCT was analyzed by 11 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about ONCT.
In the previous month the buy percentage consensus was at a similar level.
ONCT was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-09-18 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2023-09-07 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2023-06-06 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-04-04 | Cantor Fitzgerald | Maintains | Overweight |
| 2023-04-04 | Brookline Capital | Downgrade | Buy -> Hold |
| 2023-04-04 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2023-04-04 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-04-04 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-03-22 | Oppenheimer | Maintains | Outperform |
| 2023-03-14 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-12-22 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-08-10 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-10 | Maxim Group | Initiate | Buy |
| 2022-02-24 | BTIG | Initiate | Buy |
| 2021-04-07 | Oppenheimer | Initiate | Outperform |
| 2021-03-30 | Brookline Capital | Initiate | Buy |
| 2021-03-12 | HC Wainwright & Co. | Maintains | Buy |